Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-27

Clinical Trial Update: Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating verinurad and allopurinol in combination with cyclosporine and rifampicin in healthy volunteers with chronic kidney di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)
  • CYCLOSPORINE (cyclosporine)
  • Rifampicin
  • Verinurad (verinurad)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-03-27